Re (RMAX) Cash & Equivalents (2012 - 2026)

Re (RMAX) has 15 years of Cash & Equivalents data on file, last reported at $107.1 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 20.22% year-over-year to $107.1 million in Q1 2026; TTM through Mar 2026 was $107.1 million, a 20.22% increase from a year earlier, with the FY2025 full-year figure at $118.7 million, up 22.89% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $107.1 million, down from $118.7 million in the prior quarter.
• Over the last five years, Cash & Equivalents for RMAX reached as high as $118.7 million in Q4 2025 and fell as low as $66.1 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $98.5 million across 5 years, with a median of $96.8 million in 2023.
• Across the five-year window, Cash & Equivalents sank 31.72% in 2024 and jumped 42.76% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $108.7 million in 2022, then declined by 23.96% to $82.6 million in 2023, then rose by 16.94% to $96.6 million in 2024, then grew by 22.89% to $118.7 million in 2025, then decreased by 9.78% to $107.1 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $107.1 million in Q1 2026, $118.7 million in Q4 2025, and $107.5 million in Q3 2025.